-

Spineology® Announces the Launch of OptiMesh Align™

– This latest breakthrough offers one of the broadest expansion ranges in height, width and now lordotic shape available on the expandable spinal implant market –

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc., the pioneers of Conform and Expand™ Technology, today announced the launch of its latest innovation, and most advanced patient specific solution yet: OptiMesh Align™ (Align). Built on the proven foundation of OptiMesh®, Align is uniquely engineered to provide real time, in-situ, independent anterior and posterior implant expansion resulting in a customized, patient specific lordotic shape up to 20 degrees. Align is delivered through one of the smallest insertion profiles available, expanding to one of the largest implant footprints, enabling correction not typically associated with minimally invasive posterior spine approaches.

OptiMesh utilizes a biologics-based expansion method, which is designed to overcome limitations and reduce point-loading commonly seen with mechanically expandable implant technology.

“Sagittal alignment is widely considered one of the key correlative indicators to achieving long term clinical success for spine patients. The OptiMesh technology remains the only conforming expandable implant that offers a personalized solution for each patient,” said Brian Snider, Chief Executive Officer. “With the addition of the lordotic capabilities of the Align implant, our portfolio provides more options to achieve the clinical requirements of surgery.”

OptiMesh Align is engineered to produce distraction forces and endplate conformance, provide strength and stability to restore disc height, create a robust fusion scaffold, and now further supports the achievement of alignment objectives. This breakthrough is driven by Spineology’s proprietary Conform and Expand flexible mesh interbody technology, setting a new standard for patient specific lumbar interbody fusion.

About Spineology

Spineology Inc. are the pioneers of Conform and Expand™ technology, a novel development method used in the design of spinal expandable implants. Spineology’s core portfolio, OptiMesh® is the only conforming patient specific spinal implant on the market. OptiMesh is backed with IDE level data which further sets the company apart from traditional fusion procedures. OptiMesh is designed to enable surgeons to support outcomes, and patient recovery while minimizing tissue disruption. With a strong commitment to patient-centered care, Spineology aspires to provide every spine patient the freedom from pain through the creation and delivery of ultra-MIS solutions.

For more information about Spineology, visit Spineology.com, and follow us on LinkedIn, or Twitter.

Contacts

Steve Nemitz
Chief Financial Officer
651-256-8500
snemitz@spineology.com

Spineology Inc.


Release Summary
Spineology is announcing the launch of OptiMesh Align, the company's latest and most advanced patient specific solution yet.
Release Versions

Contacts

Steve Nemitz
Chief Financial Officer
651-256-8500
snemitz@spineology.com

More News From Spineology Inc.

Spineology® Announces Organization Rebrand

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc., today unveiled a new brand and visual identity, logo, and product positioning as part of an extensive rebranding initiative....

Spineology® Announces $25 Million Equity Financing

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology, the medical device company pioneering Conform and Expand™ spinal fusion technology, today announced that it has raised $25 million in Series AA financing led by SV Health Investors, with participation from 1315 Capital and its existing investor, RC Capital. “We are thrilled to welcome SV Health Investors and 1315 Capital. This infusion of capital allows us to provide our offering more rapidly to patients and clinical programs across the country,” sa...

Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years. “The addition of Emory adds even further con...
Back to Newsroom